Tricyclic compound and JAK inhibitor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9890165
SERIAL NO

15307036

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel tricyclic compounds which have JAK inhibitory activities are useful for prevention, treatment or improvement of autoimmune diseases, inflammatory diseases and allergic diseases are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NISSAN CHEMICAL CORPORATIONTOKYO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hayashi, Keishi Funabashi, JP 18 1027
Iwamoto, Shunsuke Funabashi, JP 20 90
Kamiyama, Toshihiko Funabashi, JP 8 2
Kurihara, Kazunori Funabashi, JP 10 71
Minami, Masataka Funabashi, JP 97 2578
Nakamura, Takanori Shiraoka, JP 62 372
Nishimura, Takuya Funabashi, JP 116 1306
Takahashi, Keiji Funabashi, JP 96 1024
Uni, Miyuki Funabashi, JP 4 11
Watanabe, Tsuneo Funabashi, JP 58 519
Yamamoto, Akio Funabashi, JP 196 3818

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 13, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 13, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00